SG Americas Securities’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23K Sell
23,671
-85,930
-78% -$83.5K ﹤0.01% 2473
2025
Q1
$158K Sell
109,601
-41,881
-28% -$60.4K ﹤0.01% 2408
2024
Q4
$333K Buy
151,482
+74,433
+97% +$164K ﹤0.01% 1485
2024
Q3
$127K Buy
77,049
+39,635
+106% +$65.3K ﹤0.01% 2547
2024
Q2
$83K Buy
37,414
+11,658
+45% +$25.9K ﹤0.01% 2258
2024
Q1
$69K Buy
+25,756
New +$69K ﹤0.01% 2357
2023
Q2
Sell
-14,994
Closed -$24K 2198
2023
Q1
$24K Sell
14,994
-975
-6% -$1.56K ﹤0.01% 2854
2022
Q4
$99K Sell
15,969
-66,920
-81% -$415K ﹤0.01% 2479
2022
Q3
$555K Buy
82,889
+21,306
+35% +$143K 0.01% 1279
2022
Q2
$392K Buy
+61,583
New +$392K ﹤0.01% 1968
2022
Q1
Sell
-110,514
Closed -$553K 2695
2021
Q4
$553K Buy
110,514
+8,934
+9% +$44.7K ﹤0.01% 1910
2021
Q3
$1.22M Buy
101,580
+87,736
+634% +$1.06M 0.01% 1575
2021
Q2
$293K Sell
13,844
-2,422
-15% -$51.3K ﹤0.01% 1967
2021
Q1
$456K Buy
16,266
+717
+5% +$20.1K ﹤0.01% 1896
2020
Q4
$404K Sell
15,549
-8,270
-35% -$215K ﹤0.01% 1887
2020
Q3
$885K Buy
23,819
+18,405
+340% +$684K 0.01% 1042
2020
Q2
$278K Sell
5,414
-22,238
-80% -$1.14M ﹤0.01% 2205
2020
Q1
$872K Buy
27,652
+7,089
+34% +$224K 0.01% 1107
2019
Q4
$1.23M Buy
+20,563
New +$1.23M 0.01% 984
2019
Q2
Sell
-14,840
Closed -$596K 2635
2019
Q1
$596K Buy
14,840
+10,435
+237% +$419K 0.01% 1479
2018
Q4
$203K Buy
+4,405
New +$203K ﹤0.01% 2021
2018
Q3
Sell
-27,319
Closed -$1.07M 2666
2018
Q2
$1.07M Sell
27,319
-63,654
-70% -$2.5M 0.01% 1229
2018
Q1
$6.58M Buy
90,973
+87,950
+2,909% +$6.36M 0.05% 276
2017
Q4
$199K Sell
3,023
-400
-12% -$26.3K ﹤0.01% 2048
2017
Q3
$172K Sell
3,423
-3,585
-51% -$180K ﹤0.01% 2364
2017
Q2
$324K Buy
7,008
+2,991
+74% +$138K ﹤0.01% 1880
2017
Q1
$142K Sell
4,017
-4,045
-50% -$143K ﹤0.01% 2397
2016
Q4
$101K Buy
+8,062
New +$101K ﹤0.01% 2531
2015
Q3
Sell
-4,487
Closed -$367K 2126
2015
Q2
$367K Buy
+4,487
New +$367K ﹤0.01% 1433